Drug research

Fasedienol Nasal Spray

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)NCT06615557	VTGN	Phase 3	Active not recruiting	2026-04-21Actual
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)NCT06358651	VTGN	Phase 3	Active not recruiting	2025-10-31Actual

VTGNActive not recruitingPrimary completion: 2026-04-21 · Actual

Trial details

VTGNActive not recruitingPrimary completion: 2025-10-31 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.